Literature DB >> 28793355

Effects of Cannabidiol on Morphine Conditioned Place Preference in Mice.

James Roland Markos1, Hannah M Harris1, Waseem Gul2,3, Mahmoud A ElSohly2,4,3, Kenneth J Sufka1,2.   

Abstract

This study sought to determine whether the cannabis constituent cannabidiol attenuates the development of morphine reward in the conditioned place preference paradigm. Separate groups of mice received either saline or morphine in combination with one of four doses of cannabidiol using three sets of drug/no-drug conditioning trials. After drug-place conditioning, morphine mice displayed robust place preference that was attenuated by 10 mg/kg cannabidiol. Further, when administered alone, this dose of cannabidiol was void of rewarding and aversive properties. The finding that cannabidiol blocks opioid reward suggests that this compound may be useful in addiction treatment settings. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28793355     DOI: 10.1055/s-0043-117838

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  12 in total

Review 1.  Cannabinoids, Pain, and Opioid Use Reduction: The Importance of Distilling and Disseminating Existing Data.

Authors:  Kent E Hutchison; Sarah L Hagerty; Jeffrey Galinkin; Angela D Bryan; L Cinnamon Bidwell
Journal:  Cannabis Cannabinoid Res       Date:  2019-09-23

2.  Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms.

Authors:  Ewa Galaj; Guo-Hua Bi; Hong-Ju Yang; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2019-08-19       Impact factor: 5.250

Review 3.  Cannabidiol and substance use disorder: Dream or reality.

Authors:  Saeideh Karimi-Haghighi; Yasaman Razavi; Daniela Iezzi; Andrew F Scheyer; Olivier Manzoni; Abbas Haghparast
Journal:  Neuropharmacology       Date:  2022-01-13       Impact factor: 5.273

Review 4.  Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Authors:  Ewa Galaj; Zheng-Xiong Xi
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

5.  Cannabidiol attenuates methamphetamine-induced conditioned place preference via the Sigma1R/AKT/GSK-3β/CREB signaling pathway in rats.

Authors:  Genmeng Yang; Liu Liu; Ruilin Zhang; Juan Li; Chi-Kwan Leung; Jian Huang; Yuanyuan Li; Baoyu Shen; Xiaofeng Zeng; Dongxian Zhang
Journal:  Toxicol Res (Camb)       Date:  2020-05-09       Impact factor: 3.524

6.  Cannabinoid-2 Agonism with AM2301 Mitigates Morphine-Induced Respiratory Depression.

Authors:  Beth M Wiese; Erika Liktor-Busa; Aidan Levine; Sarah A Couture; Spyros P Nikas; Lipin Ji; Yingpeng Liu; Kenneth Mackie; Alexandros Makriyannis; Tally M Largent-Milnes; Todd W Vanderah
Journal:  Cannabis Cannabinoid Res       Date:  2020-11-13

Review 7.  The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder.

Authors:  Yann Chye; Erynn Christensen; Nadia Solowij; Murat Yücel
Journal:  Front Psychiatry       Date:  2019-02-19       Impact factor: 4.157

Review 8.  Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders.

Authors:  Francisco Navarrete; María Salud García-Gutiérrez; Ani Gasparyan; Amaya Austrich-Olivares; Jorge Manzanares
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

9.  Adolescent THC exposure does not sensitize conditioned place preferences to subthreshold d-amphetamine in male and female rats.

Authors:  Robin J Keeley; Cameron Bye; Jan Trow; Robert J McDonald
Journal:  F1000Res       Date:  2018-03-20

Review 10.  Emerging Evidence for Cannabis' Role in Opioid Use Disorder.

Authors:  Beth Wiese; Adrianne R Wilson-Poe
Journal:  Cannabis Cannabinoid Res       Date:  2018-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.